Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20120430009593N15Phase 3Completed
Phase 3, randomised, double-blind trial in opioid use disorder (OUD) comparing Dexamethasone with Dexmedetomidine (2 arms). Primary endpoints: Onset of sensory block, Onset of motor block and 3 more. Started Dec 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20120430009593N15.